Long-Term Safety And Tolerability Of Indacaterol/glycopyrrolate In Moderate-To-Severe COPD Patients From The Us: A Subgroup Analysis From The Flight3 Study

被引：0
|
作者：
Ferguson, G. T. [1 ]
Schubert-Tennigkeit, A. A. [2 ]
Thach, C. [3 ]
Banerji, D. [4 ]
机构：
[1] Southeast Michigan, Pulm Res Inst, Farmington Hills, MI USA
[2] Novartis Pharma AG, Basel, Switzerland
[3] Novartis Pharmaceut, East Honover, NJ USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2016年 / 193卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6788
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Long-Term Maintenance Bronchodilation With Indacaterol/Glycopyrrolate Versus Indacaterol in Moderate-to-Severe COPD Patients: The FLIGHT 3 Study
    Ferguson, Gary T.
    Taylor, Angel Fowler
    Thach, Chau
    Wang, Qian
    Schubert-Tennigkeit, Agnes A.
    Patalano, Francesco
    Banerji, Donald
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2016, 3 (04): : 716 - 728
  • [2] Safety Of Indacaterol/glycopyrrolate Versus Its Monocomponents And Placebo In Us Patients With Moderate-To-Severe COPD: A Subgroup Analysis From The Flight1 And Flight2
    Kerwin, E.
    FowlerTaylor, A.
    Thach, C.
    Larbig, M.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [3] Improvement In Lung Function With Twice-Daily Indacaterol/glycopyrrolate Versus Once-Daily Indacaterol In Patients With Moderate-To-Severe COPD: Results From The Flight3 Study
    Mahler, D. A.
    Ferguson, G. T.
    Fucile, S.
    Yadao, A.
    Wang, Q.
    Ayers, T.
    Fogel, R.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [4] Safety Of Indacaterol/glycopyrrolate 27.5/15.6 μg Twice Daily In Patients With Moderate-To-Severe COPD: Analysis From The Flight Studies
    Ferguson, G. T.
    Donohue, J. F.
    Fucile, S.
    Yadao, A.
    Maitra, S.
    Ayers, T.
    Fogel, R.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [5] Indacaterol/glycopyrrolate Improves Dyspnea In Us Patients With Moderate-To-Severe COPD: A Subgroup Analysis Of The Pooled Flight1 And Flight2 Studies
    Mahler, D. A.
    Maitra, S.
    Fogel, R.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [6] Long-term safety of glycopyrrolate: A randomized study in patients with moderate-to-severe COPD (GEM3)
    Mahler, Donald A.
    Gifford, Alex H.
    Satti, Aditi
    Jessop, Nicola
    Eckert, Joerg H.
    D'Andrea, Peter
    Mota, Fernando
    Banerjee, Rudrani
    RESPIRATORY MEDICINE, 2016, 115 : 39 - 45
  • [7] Indacaterol/glycopyrrolate Significantly Improves COPD Assessment Test (cat) Scores In Us Patients With Moderate-To-Severe COPD: Subgroup Analysis From Pooled Flight1 And Flight2 Studies
    Fogel, R.
    Maitra, S.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [8] Improvement In Lung Function With Indacaterol/glycopyrrolate (ind/gly) In Patients With Moderate To Severe COPD From The Us: A Subgroup Analysis From The Flight1 And Flight2 Studies
    Kerwin, E.
    Mahler, D. A.
    FowlerTaylor, A.
    Maitra, S.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [9] Safety Of Inhaled Glycopyrrolate In Patients With Moderate-To-Severe COPD: Subgroup Analysis From The Pooled Data Of Four Clinical Trials
    D'Andrea, P.
    LaForce, C.
    Pedinoff, A.
    Miller, S.
    Yadao, A.
    Uddin, A.
    Franke-Bray, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [10] Improvement In Trough Fev1 With Indacaterol/glycopyrrolate In Patients With Moderate-To-Severe COPD: A Pooled Subgroup Analysis Of The Flight1 And Flight2 Studies
    Ferguson, G. T.
    Kerwin, E. M.
    Fucile, S.
    Yadao, A.
    Maitra, S.
    Ayers, T.
    Fogel, R.
    Patalano, F.
    Banerji, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345